T. Rowe Price Capital Appreciation Fund (PRWCX)
Ticker Symbol:
PRWCX
Fund Status:
Closed to new Retail investors  /  Open to subsequent Retail investments
Closed to new Retail Investors as of June 30, 2014 at 4pm EST
Fund Composition
Asset Allocation
as of 08/31/2016
Domestic Stock 59.8%
Domestic Bond 22.9%
Cash 8.6%
Foreign Bonds 4.0%
Foreign Stock 3.4%
Convertibles 1.3%
Preferreds 0.9%
Options -0.6%
Volatility and Other Measures
as of 08/31/2016
Beta 0.63
0.93
Standard Deviation 6.96
Price/Earnings Ratio (Domestic) 19.0
Earnings Growth Rate (Domestic) 11.2
Turnover Rate 35.8
Median Market
Capitalization
$56,216.73 Million
Sector Diversification
as of 08/31/2016
% of Total Net Assets
Health Care 17.4%
Information Technology 9.8%
Financials 9.6%
Consumer Staples 9.0%
Consumer Discretionary 8.3%
Industrials & Business Services 4.8%
Utilities 2.6%
Real Estate 1.2%
Telecommunication Services 0.7%
Materials 0.6%
Energy 0.5%
10 Largest Holdings
Represents 25.00 % of Total Net Assets
View Holdings as of:
Abbott Laboratories
Alphabet
Bank of New York Mellon
Becton, Dickinson & Company
Danaher
Marsh & McLennan
Microsoft
PG&E
Thermo Fisher Scientific
Willis Towers Watson
As of 08/31/2016 the Capital Appreciation Fund had a total of 294 holdings.
See Glossary for additional details on all data elements.